Takeda shutting US vaccine R&D sites in global restructure
Takeda is closing three US R&D facilities and relocating its global HQ to a site in Massachusetts as part of plans to consolidate its vaccine business.
Archives for June 4, 2015
Intertek to open new lab in light of pharma demand for immunochemistry
Intertek will open an immunochemistry lab in Manchester, UK to cater for growing demand for specialised analytical services from biologics and biosimilars developers.
Bolt-ons will follow $14bn Pall deal, says M&A hungry Danaher
There are plenty of bolt-on acquisition opportunities in the bioprocessing space says Danaher, weeks after agreeing to buy Pall for $13.8bn (€12bn).
NIH’s PDS suspends manufacturing operations
The National Institutes of Health’s (NIH) Pharmaceutical Development Section (PDS), which manufactures products for clinical trials, has suspended operations due to the discovery of serious manufacturing problems and contamination by US FDA inspectors.